Antibioticss | Patient Group (clinical samples) | All | Healthy Group (colorectal samples) | |||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Range | MIC (µg/mL) | R% | Range | MIC (µg/mL) | R% | Range | MIC (µg/mL) | R% | ||||
MIC50 | MIC90 | MIC50 | MIC90 | MIC50 | MIC90 | |||||||
Penicillin G | 4->256 | 256 | >256 | 100 | 4->256 | 128 |  > 256 | 100 | 4->256 | 128 |  > 256 | 100 |
Ampicillin-sulbactam | 1–128 | 4 | 16 | 9.1 | 0.125–256 | 1 | 8 | 5.45.4 | 0.125–256 | 1 | 16 | 6.4 |
Piperacillin-tazobactam | 0.06–256 | 1 | 64 | 9.1 | 0.06–128 | 0.5 | 4 | 1.8 | 0.06–256 | 0.4 | 4 | 2.6 |
Cefoxitin | 2–256 | 16 | 256 | 45.5 | 2–256 | 8 | 256 | 35.7 | 2–256 | 16 | 256 | 38.5 |
Imipenem | 0.06–4 | 0.5 | 4 | 0 | 0.064–16 | 0.5 | 4 | 1.8 | 0.06–16 | 0.5 | 4 | 1.3 |
Meropenem | 0.064–4 | 0.25 | 2 | 0 | 0.064–16 | 0.25 | 2 | 1.8 | 0.06–16 | 0.1250.125 | 2 | 1.3 |
Tetracycline | 1–128 | 32 | 64 | 81.8 | 0.125–128 | 32 | 64 | 71.4 | 0.125–128 | 32 | 64 | 74.4 |
Clindamycin | 0.125->256 | 8 | >256 | 54.5 | 0.125->256 | 2 | 256 | 42.9 | 0.125->256 | 16 | 256 | 41 |
Metronidazole | 0.06–4 | 0.52 | 2 | 0 | 0.06–1 | 0.25 | 0.5 | 0 | 0.06–4 | 0.25 | 2 | 0 |